Lutsiak V. The constituent elements and the method for estimating dynamic capabilities of small production enterprises.

Authors

  • Віталій Луцяк Національний університет харчових технологій, м. Київ, Ukraine

DOI:

https://doi.org/10.31498/2225-6407.12.2015.82061

Keywords:

dynamic capabilities, a small production enterprise, method of quantitative evaluation, individual level of innovation, human capital, innovative results, modernization, financial performance innovation.

Abstract

The enterprises ability to systematically anticipate changes in the environment and respond to them is important in competition. An important theoretical and practical task is to study quantitative methods for measuring dynamic capabilities (DC), which devoted a significant amount of scientific publications in the world. Recent studies indicate the practical absence of standardized or conventional teaching materials to keep track of DC state development, while highlights certain features in the formation of small enterprise DC.

In this paper we propose a method for assessing the level of small production enterprise DC based its structural features and formulate directions for further research in this area. There are proposed a three-tier DC evaluation system of small production enterprise, consisting of partial, consolidated and synthesis rate. Partial indicators by measuring different local innovation processes, assess the size and extent of individual aspects of the structural components of the enterprise DC. Consolidated indicators are selection criteria of current and future directions for improving the structural components of the enterprise DC. Provides a summary measure of the resulting assessment of enterprise DC and demonstrates its degree of adaptability to market conditions.

Further study proposed to develop innovative results of the company; the formation of its human capital; finance, reflecting the state of innovation processes of the enterprise; modernization and new acquisitions.

Author Biography

Віталій Луцяк, Національний університет харчових технологій, м. Київ

к.т.н., докторант

References

Гребешкова О.М. Динамічні здатності підприємства: способи виявлення та відстеження розвиненості / О.М. Гребешкова, О.Г. Малярчук // БІЗНЕСІНФОРМ. № 7. – 2013. – С. 321-326.

Малыгина О.В. Модель компетентности организации как инструмент оценки инновационного развития [Електронний ресурс] / О.В. Малыгина // Интернет-журнал «Науковедение». – Вып. 6 (25). – 2014 ноябрь-декабрь. URL: http://naukovedenie.ru/PDF/108EVN614.pdf

Barney, J. (1991). Firm resources and sustained competitive advantage. J. Management, 17, 99-120.

Barreto, I. (2010). Dynamic capabilities: A review of past research and an agenda for the future. Journal of Management, 36(1), 256-280.

Bruni, D. S., & Verona, G. (2009). Dynamic marketing capabilities in science-based firms: An exploratory investigation of the pharma-ceutical industry. British Journal of Management, 20(Suppl. 1), S101-S117.

Cockburn, I. M., Henderson, R. M., Stern, S. (2000). Untangling the origins of competitive advantage. Strategic Management J., 21, 1123-1145.

Eisenhardt, K. M., & Martin, J. A. (2000). Dynamic capabilities: What are they? Strategic Management Journal, 21(10), 1105-1121.

Eriksson, T. (2013). Processes, antecedents and outcomes of dynamic capabilities. Scandinavian Journal of Management. Retrieved from http://dx.doi.org/10.1016/j.scaman.2013.05.001.

Felin, T., Foss, N. J. (2005). Strategic organization: A field in search of micro-foundations. Strategic Organ., 3, 441-455.

Helfat, C. E., & Peteraf, M. A. (2003). The dynamic resource-based view: Capability lifecycles. Strategic Management Journal, 24(10), 997-1010.

Henderson, R. M., I. Cockburn. (1994). Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management J., 15, 63-84.

Hung, R. Y., Chung, T., & Lien, B. Y. (2007). Organizational process alignment and dynamic capabilities in high-tech industry. Total Quality Management & Business Excellence, 18(9), 1023-1034.

Lacetera, N., I. Cockburn, R. M. Henderson. (2004). Do firms change capabilities by hiring new people? A study of the adoption of science-based drug discovery. J. A. C. Baum, A. M. McGahan, eds. Business Strategy over the Industry Lifecycle: Advances in Strategic Management, Elsevier, Boston, MA, Vol. 2, 1133-159.

Macpherson, A., Jones, O., & Zhang, M. (2004). Evolution or revolu-tion? Dynamic capabilities in a knowledge-dependent firm. R&D Management, 34(2), 161-177.

Morgan, N. A., Vorhies, D. W., & Mason, C. H. (2009). Market orientation, marketing capabilities, and firm performance. Strategic Management Journal, 30(8), 909-920 [in English].

Nelson & Winter. (1982). The cornerstones of competitive advantage: A resource-based view. Strategic Management J., 14, 179-191.

Ranft, A. L., Lord, M. D. (2002). Acquiring new technologies and capabilities: A grounded model of acquisition implementation. Organ. Sci., 13, 420-441.

Rothaermel, F. T., & Hess, A. M. (2007). Building dynamic capabili-ties: Innovation driven by individual-, firm-, and network-level effects. Organization Science, 18(6), 898-921.

Rousseau, D. M., & Denyer, D. (2008). Evidence in management and organizational science: Assembling the field’s full weight of scientific knowledge through syntheses. Academy of Management Annals, 2(1), 475-515.

Slater, S. F., Olson, E. M., & Hult, G. T. M. (2006). The moderating influence of strategic orientation on the strategy formation capability – performance relationship. Strategic Management Journal, 27(12), 1221-1231.

Teece, D. J. (1992). Competition, cooperation, and innovation: Organizational arrangements for regimes of rapid technological progress. J. Econom. Behav. Organ., 18, 1-25.

Teece, D., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.

Zucker, L. G., Darby, M. R., Armstrong, J. S. (2002). Commercializing knowledge: University science, knowledge capture, and firm performance in biotechnology. Management Sci., 48, 138-153.

Zucker, L. G., Darby, M. R. (1997). Present at the biotechnological revolution: Transformation of technological identity for a large incumbent pharmaceutical firm. Res. Policy, 26, 429-446.

Published

2015-12-03